Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about Fibro sarcoma, 3 relevant journals, 22 Conference Proceedings, 1 Open Access Articles, 4 National Symposiums are presently dedicated exclusively to Cancer Field.
Fibro sarcoma is a tumor of mesenchymal cell origin that is composed of malignant fibroblasts in a collagen background. It can occur as a soft-tissue mass or as a primary or secondary bone tumor.
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Fibro sarcoma was diagnosed much more frequently in the past; it is now more reliably distinguished histologically from similar lesions, such as desmoid tumors, malignant fibrous histiocytoma, malignant schwannoma, and high-grade osteosarcoma. These tumors are difficult to classify and are often thought of as a group because of the parallel resemblance in their presentation. Therefore, there are several different names in addition to fibrosarcoma that you may hear when this category of tumors is discussed. Neurofibromas, peripheral nerve sheath tumors, spindle cell tumors, schwannoma, and hemangiopericytomas are all names for fibro sarcoma.The field of translational genomics is rapidly progressing, yet the systematic application of current knowledge to improve patient care remains a formidable challenge. National symposiums and Workshops provide a dedicated forum for the advancement, implementation and exchange of information about Genomics and its allied areas. Around 20 National symposiums and Workshops are going to be held across the globe which includes “Genetic and Rare Diseases information Center”.
Surgery is the primary treatment for this type of tumor. Surgical treatment can range from removal of the lump to, in extreme cases, removal of the affected limb, if necessary. Radiotherapy, alone or in addition to surgery (which is more often the case), can be of benefit, while chemotherapy is generally less effective. In some cases, having your pet evaluated by a veterinarian who specializes in treating cancer, an oncologist, will be advantageous. With fibro sarcomas, it is important to keep in mind that complete removal is usually not possible due to the tumor’s location, as well as its invasive nature. It is difficult to remove the tumor and surrounding tissue and still leave enough skin to close the site with sutures; consequently, recurrence is fairly frequent.
Market Analysis :
The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.
International symposium and workshops
ASRT Radiation Therapy Conference, October 18-20, 2015, San Antonio, Texas
Annual Radiotherapy Conference, January 30 – February 1, 2015, Thistle Bristol City Centre, The Grand Broad Street, England
ASRT Radiation Therapy Conference, October 18-20, 2015, San Antonio, Texas.
Annual Radiotherapy Conference, January 30 – February 1, 2015, Thistle Bristol City Centre, The Grand Broad Street, England
RTi3: Radiation Therapy Conference 2015, March 6 – 7, 2015, Chestnut Conference Centre, Toronto
Creating a Better Future For Cancer Patients Worldwide , Mar30- Apr 02 , 2015 , Pentagon City – Arlington, VA, United States
List of Best International Conferences
Pancreatic and Colorectal Cancer
March 29-30, 2016 Atlanta, USA.
Blood Malignancies and Treatment
April 18-20, 2016 Dubai, UAE.
Gynecologic Oncology
May 19-21, 2016 San Antonio, USA.
Antimicrobial Agents and Chemotherapy
June 6-7, 2016 Dallas, USA.
Cancer Diagnostics Conference & Expo
June 13-15, 2016 Rome, Italy.
10th Global Oncologists Annual Meeting
July 11-13, 2016 Cologne, Germany.
11th Asia-Pacific Oncology and Oncologists Meeting
July 11-13, 2016 Kuala Lumpur, Malaysia.
Melanoma and Carcinoma
July 14-15, 2016 Brisbane, Australia.
Neuro Onclogy
July 21-23, 2016 Brisbane, Australia.
Thyroid Cancer and Treatment
Aug 1-3, 2016 Toronto, Canada.
Oral, Mouth and Throat Cancer
Aug 18-20, 2016 Portland, Oregon.
Molecular & Cancer Biomarkers
Sept 15-17, 2016 Berlin, Germany.
Cervical Cancer
Sept 22-23, 2016 Vienna, Austria.
Radiation Oncology
Sep 26-28, 2016 Valencia, Spain.
12th Euro Global Summit on Cancer Therapy
Sept 26-28, 2016 London, UK.
13th Global Oncologists Summit and Cancer Therapy
Oct 17-19, 2016 Dubai, UAE.
Mesothelioma
Nov 3-4, 2016 Valencia, Spain.
Leukemia and Bone marrow Transplantation
Nov 10-12, 2016 Istanbul, Turkey.
14th Cancer Therapy
Dec 8-10, 2016 Baltimore, USA.
2nd Prostate Cancer and Treatment Conference
May 5-7,2016, Chicago, USA.
Relevant Society and Associations
American Society for Radiation Oncology.
American Cancer Society.
Cancer Research UK.
British Association of Urological Surgeons (BAUS).
National Cancer Institute.
Cancer society of New Zealand.
American society of clinical oncology.
Cancer Research foundation.
Cancer Research Institute.
Urological Association of Asia and Iranian.
Canadian Cancer Society.
List of Companies
IBA Proton Therapy.
Sun Nuclear.
Elekta, Inc.
RaySearch Laboratories.
Modus Medical Devices Inc.
PI (Physik Instrumente) L.P. Piezo Nanopositioning.
Accuray.
VARIAN Medical Systems Particle Therapy GmbH.
CIRS.
LifeLine Software, Inc./RadCalc.
This page will be updated regularly.
This page was last updated on November 24, 2024
